NCT00422877View on ClinicalTrials.gov

Taxoprexin® Treatment for Advanced Primary Cancers of the Liver, Gallbladder or Biliary Tract

PHASE2TerminatedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Cancer of the Liver
Interventions
DRUG

Taxoprexin

Administered by intravenous infusion over 1 hour infusion

Trial Locations (1)

77030

University of Texas, MD Anderson Cancer Center, Houston

Sponsors
All Listed Sponsors
lead

American Regent, Inc.

INDUSTRY